ARALEZ PHARMACEUTICALS INC. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2016-02-19: Federal exemption Rule 506(b); Types of securities offered Debt; OptionToAcquire; SecurityToBeAcquired; "Each Senior Secured Convertible Note bears interest at 2.5% for up to 6 years with the ""Conversion Price"" defined in the 3 convertible notes."; Date of first sale 2016-02-05; Total offering amount $75,000,000.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|---|---|---|---|---|---|---|
| 2016-02-19 | Rule 506(b) | Debt; OptionToAcquire; SecurityToBeAcquired; "Each Senior Secured Convertible Note bears interest at 2.5% for up to 6 years with the ""Conversion Price"" defined in the 3 convertible notes." | 2016-02-05 | $75,000,000 | $75,000,000 | $0 | 3 |